Colorectal cancer metastatic | Secondary malignant neoplasm of female breast | Start Therapeutic procedure
Item
metastatic colorectal or breast cancer patients commencing treatment on one of four specified regimens
boolean
C0948380 (UMLS CUI [1])
C0346993 (UMLS CUI [2])
C0439659 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
Colorectal cancer metastatic
Item
for metastatic colorectal cancer:
boolean
C0948380 (UMLS CUI [1])
Capecitabine Dosage | Oxaliplatin Dosage | CAPOX Regimen
Item
capecitabine 2000mg/m2 d 1-14, q 3 weekly and oxaliplatin 130mg/m2 d1 q 3 weekly (capox)
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0069717 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C1879915 (UMLS CUI [3])
Capecitabine Dosage
Item
capecitabine 2500mg/m2 d 1-14, q 3 weekly
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Secondary malignant neoplasm of female breast
Item
for metastatic breast cancer:
boolean
C0346993 (UMLS CUI [1])
Capecitabine Dosage
Item
capecitabine 2000mg/m2d 1-14, q 3 weekly
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Capecitabine Dosage | Docetaxel Dosage
Item
capecitabine 2000mg/m2 d 1-14, q 3 weekly and docetaxel 75mg/m2 d1 q 3 weekly
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0246415 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Fit Pharmaceutical Preparations Dose Full
Item
fit to start at full (100%) starting dose of all drugs
boolean
C0424576 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0443225 (UMLS CUI [1,4])
Able to operate mobile phone | Use of Mobile Phone Willing
Item
able and willing to use mobile phone
boolean
C4274610 (UMLS CUI [1])
C1524063 (UMLS CUI [2,1])
C1136360 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Renal function | Liver function | Bone Marrow function
Item
reasonable renal, liver and bone marrow function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
Absolute neutrophil count
Item
absolute neutrophil count (anc) >1.5 x 109/l
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count > 100 x 109/l
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement
Item
total bilirubin <1.5 uln
boolean
C1278039 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
alt, ast < 2.5 x uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Alkaline phosphatase measurement
Item
alkaline phosphatase < 2.5 x uln
boolean
C0201850 (UMLS CUI [1])
Absence Medical contraindication Capecitabine | Absence Medical contraindication Oxaliplatin | Absence Medical contraindication Docetaxel
Item
no obvious contra indications to capecitabine or oxaliplatin or docetaxel
boolean
C0332197 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C0671970 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0069717 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C1301624 (UMLS CUI [3,2])
C0246415 (UMLS CUI [3,3])
Able to read English Language | Able to write English Language | Comprehension English Language
Item
patients must also be able to read, write and understand english.
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0233733 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
Residence | Mobile Phone Network Lacking | Other Coding
Item
patients who live in an area of no vodafone or orange mobile phone network - -
boolean
C0237096 (UMLS CUI [1])
C1136360 (UMLS CUI [2,1])
C1882071 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
C3846158 (UMLS CUI [3])
Study Subject Participation Status | Cancer treatment
Item
patients participating in other cancer treatment trials
boolean
C2348568 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
Renal Insufficiency Moderate | Renal Insufficiency Severe | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
moderate or severe renal impairment [creatinine clearance <30ml/min (calculated according to cockroft-gault formula)]
boolean
C1565489 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C1565489 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C2711451 (UMLS CUI [3])